BioNTech SE (BNTX) Deep Dive Video
Summary
A cash-fortified mRNA pioneer tries to turn its COVID windfall into a 2030 oncology franchise—while racing competitors and replacing its founders.
View BNTX stock page · Read the BNTX research report
Loading the video player…